Bellerophon therapeutics inc.

Major-Pharmaceuticals

BLPH


184 Liberty Corner Road
Warren , NJ 07059

Executive/
Director

Price

  • Last Close
  • $ 0.1
    $ -0.29 -74.06 %
    Oct 13, 2023
  • 52-Week High/Low
  • $0.46 - $0.1
  • YTD
  • 0%

  • Trading Volume
  • 14,949,014
  • Market Cap Full
  • $ 1.2M
  • Shares Outstanding
  • 12.2M
    Nov 10, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -16.9% 186.5% -19.4% -18.4% -5% -23.2% -23.9% 776.7% -
Q2 -13.6% -28.1% -10.1% 19.8% -2% 4% -6.7% -47.9% -91.3% -
Q3 -34.6% -20.9% 6% -56.6% -12.1% 8% -18.4% -11.4% -42% -
Q4 -43% -62.9% 74.3% -25.9% -35.8% -33.6% -21.5% -17.4% -74% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 116.1% -9% 345.8% -3% -9.7% -90% -34.6% -4.4% -7.2% -74.3% - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-82%396%-69%-56%1830%-54%-71%-89%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.27 0.54 0.15 -0.04 -0.01 -1.08 -0.58 -0.59 0.27
Q2 0.90 0.39 0.12 -0.2 -0.06 -0.51 -0.36 -0.43 -0.42
Q3 0.86 0.30 0.22 -0.1 -0.06 -0.84 -0.49 -0.53 -0.16
Q4 0.82 0.35 0.24 - -0.93 -0.74 -0.44 -0.53 -
A 3.9 1.6 0.7 -5.1 -3 -3.2 -1.9 -2.1 -0.31

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 68.9 - 9.5 9.5 10.4
Jun 57.5 68.9 6.1 9.5 9.5 10.4
Sep 57.8 68.9 9.5 9.5 9.5 12.2
Dec 58.7 68.9 9.5 9.5 9.5 12.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 11 10 26 4.3 0.9
Equity multiplier - - - - 0.3